Odyssey Therapeutics to outperform peers in 6 months

Market overview

Odyssey Therapeutics raised $304 million in its IPO, signaling strong investor confidence in its pipeline. The company's focus on novel therapeutics positions it to gain market share over competitors in the next half-year.

earnings prediction market

Implied probability (Yes)

68%

Source: user-generated

More earnings markets

• Anthropic's share of enterprise AI spend remains above 50% by 2026-12-31 — 72% Yes
• Munich Re’s private credit losses exceed $500M in 2026 — 72% Yes
• U.S. banks to raise dividend payout ratios by Q4 2026 — 70% Yes
• Lone Pine Capital AUM exceeds $50 billion by 2026-12-31 — 75% Yes
• Chinese AI Firms Outperform US Peers in Q4 — 60% Yes
• Samsung-led investment in Config will outperform peer VC rounds in robotics — 72% Yes
• Meta's AI compute capacity rental revenue exceeds $1B by 2027-06-30 — 60% Yes
• SpaceX's valuation reaches $2.1 trillion by Q2 2027 due to Starship success — 68% Yes

Browse all earnings markets →